Cargando…
Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy
OBJECTIVE: To validate the Intra-aortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) score in patients with cardiogenic shock after ST elevation myocardial infarction (STEMI) treated with pharmacoinvasive strategy (PhIS) and to analyse the influence of ischaemia time on different risk strata...
Autores principales: | Moraes, Pedro Ivo M, Alves, Claudia Rodrigues, Souza, Marco Tulio, Kawakami, Suzi Emiko, Goncalves Jr, Iran, Barbosa, Adriano Henrique Pereira, Moreno, Antonio Celio, Caixeta, Adriano Mendes, Carvalho, Antonio Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667936/ https://www.ncbi.nlm.nih.gov/pubmed/31413846 http://dx.doi.org/10.1136/openhrt-2019-001069 |
Ejemplares similares
-
PRospective REgistry of PAtients in REfractory cardiogenic shock—The PREPARE CardShock registry
por: von Lewinski, Dirk, et al.
Publicado: (2022) -
Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021) -
SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry
por: Morici, Nuccia, et al.
Publicado: (2022) -
IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023) -
Impella versus IABP in acute myocardial infarction complicated by cardiogenic
shock
por: Alushi, Brunilda, et al.
Publicado: (2019)